Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid Therapy in Adult Idiopathic Nephrotic Syndrome
NCT02298335Completed
- Sponsor
- Nanjing University School of Medicine
- Start
- May 2014
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisone in Idiopathic nephrotic syndrome (INS), sponsored by Nanjing University School of Medicine. Primary endpoint: Cumulative Complete Remission Rate at 8 weeks. Started May 2014; status: completed.
02
Drugs
prednisone
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on NCT02298335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298335.